Skin Infections | The Truth About Skin Care

{ Tag Archives } Skin Infections

Dermatologic Infections In Cancer Patients Treated With EGFRI Therapy

Patients who experience dermatologic toxic effects from epidermal growth factor receptor inhibitors (EGFRIs) have a high prevalence of skin and nail infections, according to a new study published online December 9 in the Journal of the National Cancer Institute…

Also tagged Cancer Patients, Cancer Therapy, Growth Factor Receptor, Journal Of The National Cancer Institute, Nail Infections, National Cancer Institute, Prevalence, Toxic Effects

2009 12 11 Skin Care News Comments Off

New Guidelines For Treating Complicated Skin And Soft Tissue Infections

New evidence-based recommendations developed by the Surgical Infection Society to guide physicians in the diagnosis and management of complicated skin and soft tissue infections have been published in Surgical Infections, a peer-reviewed journal published by Mary Ann Liebert, Inc. Surgical Infections is the Official Journal of the Surgical Infection Society (SIS) and SIS-Europe…

Also tagged Diagnosis, Europe, Mary Ann Liebert, New Evidence, Peer Reviewed Journal, Physicians, Sis, Soft Tissue Infections, Surgical Infections

2009 12 04 Skin Care News Comments Off

Regional Collaboration In Australia’s Northern Territory Reduces Skin Infections In Aboriginal Children

A community-based program aimed at reducing the burden of skin disease across remote communities in Australia’s Northern Territory has been successful according to a study published November 24 in the open-access journal PLoS Neglected Tropical Diseases.

Also tagged Aboriginal Children, Australia, Northern Territory, Open Access, Regional Collaboration, Skin Disease, Tropical Diseases

2009 11 29 Skin Care News Comments Off

Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces that its most advanced oral antibacterial NXL103 (flopristin/linopristin), has started a Phase II clinical trial in adults with acute bacterial skin and skin structure infections (ABSSSI).

Also tagged Adults, Antibacterial, Bacterial Infections, Clinical Trial, Discovery, Global Problem, Microbial Resistance, Novel Antibiotics, Oral, Pharmaceutical Company, Phase Ii, Skin And Skin, Skin Structure Infections

2009 11 07 Skin Care News Comments Off

Theravance And Astellas Announce FDA Approval Of VIBATIVTM (telavancin) For The Treatment Of Complicated Skin And Skin Structure Infections

Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved VIBATIV™ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.

Also tagged Adult Patients, Astellas Pharma Us, Astellas Pharma Us Inc, Fda, Fda Approval, Fda Approved, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Gram Positive Bacteria, Mrsa, Nasdaq, Skin And Skin, Skin Structure Infections, Staphylococcus Aureus, Strains, Telavancin, Theravance Inc, Thrx

2009 09 14 Skin Care News Comments Off

NovaBay Launches Clinical Study For Non-Antibiotic Treatment Of Impetigo, One Of The Most Common Skin Infections

NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo. NovaBay’s partner in the impetigo trial [...]

Also tagged Amex, Antibiotic Treatment, Clinical Stage, Compounds, Fungal Infections, Galderma, Impetigo, Lead, Novabay, Nyse Amex, Partner, Pharmaceuticals Inc, Phase 2a, Prevention, Proof Of Concept, Stage Company

2009 09 11 Skin Care News Comments Off

IMULAN Prepares To Initiate Trials For Atopic Dermatitis In Dogs

IMULAN BioTherapeutics, LLC announced they are prepared to commence with regulated trials to complete work on the T-Cell Receptor peptide immunomodulator, for atopic dermatitis in dogs. Canine atopic dermatitis is a very prevalent condition in dogs, thought to affect up to 5 percent of the dog population. Clinical signs of atopic dermatitis include pruritus (itching) [...]

Also tagged Atopic Dermatitis, Clinical Signs, Dermatitis, Dogs, Immunomodulator, Llc, Peptide, Population, Prevalent Condition, Pruritus Itching, Pyoderma, T Cell Receptor, Topical Skin

2009 08 06 Skin Care News Comments Off

Skin And Skin Structure Infections Are The Second Most Common Diagnoses For Which An Antibiotic Is Used In The Hospital Setting

Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that for the July – December 2008 time period, skin and skin structure infections continue to be the second most common diagnoses for which an antibiotic is used in the hospital setting. Antibiotic use for these infections [...]

Also tagged Amr, Antibiotic Use, Diagnostic Imaging, Market Intelligence, Medical Resources, Pharmaceutical Industries, Skin And Skin, Skin Structure Infections, Time Period

2009 06 23 Skin Care News Comments Off

FDA Accepts For Review Theravance’s Complete Response Submission For Telavancin For The Treatment Of Complicated Skin And Skin Structure Infections

Theravance, Inc. (NASDAQ: THRX) announced that the U.S. Food and Drug Administration (FDA) accepted as complete for review Theravance’s response to the February 2009 Complete Response letter, which outlined requirements for approval of telavancin for the treatment of complicated skin and skin structure infections (cSSSI).

Also tagged Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Nasdaq, Response Letter, Skin And Skin, Skin Structure Infections, Submission, Telavancin, Theravance Inc, Thrx

2009 04 28 Skin Care News Comments Off

The Truth About Skin Care

{ Tag Archives } Skin Infections

Dermatologic Infections In Cancer Patients Treated With EGFRI Therapy

New Guidelines For Treating Complicated Skin And Soft Tissue Infections

Regional Collaboration In Australia’s Northern Territory Reduces Skin Infections In Aboriginal Children

Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Theravance And Astellas Announce FDA Approval Of VIBATIVTM (telavancin) For The Treatment Of Complicated Skin And Skin Structure Infections

NovaBay Launches Clinical Study For Non-Antibiotic Treatment Of Impetigo, One Of The Most Common Skin Infections

IMULAN Prepares To Initiate Trials For Atopic Dermatitis In Dogs

Skin And Skin Structure Infections Are The Second Most Common Diagnoses For Which An Antibiotic Is Used In The Hospital Setting

FDA Accepts For Review Theravance’s Complete Response Submission For Telavancin For The Treatment Of Complicated Skin And Skin Structure Infections

Home

Recommendations

Free Ebook

Latest News

Site Features

Get a free ebook valued at $8.95 when you sign up for our free Skincare Tips newsletter. The book The Truth About Skincare: How To Have Younger Looking Skin sells every day for $8.95 at Bargain Books Web. It's yours at no cost by immediate download when you sign up right now. You can unsubscribe any time, and the book is yours to keep.
Name:
Email: